Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016

Highlights • Approximately half (51.6%) of NICU babies received at least one antimicrobial agent.• Amikacin was the most commonly prescribed antimicrobial agent followed by meropenem.• The recommended first-line antimicrobial agents, ampicillin and gentamicin were rarely prescribed for community acquired neonatal sepsis.

[1]  S. Chatterjee,et al.  Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India , 2007, Pharmacoepidemiology and drug safety.

[2]  C. Tebé,et al.  Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia , 2017, Antimicrobial Agents and Chemotherapy.

[3]  J. Sohn,et al.  Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli. , 2017, International journal of antimicrobial agents.

[4]  V. Pandit,et al.  Antibiotic Prescribing Pattern in a Tertiary Level Neonatal Intensive Care Unit. , 2015, Journal of clinical and diagnostic research : JCDR.

[5]  H. Goossens,et al.  The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. , 2016, The Journal of antimicrobial chemotherapy.

[6]  Megha Sharma,et al.  Up to 89% of neonates received antibiotics in cross‐sectional Indian study including those with no infections and unclear diagnoses , 2017, Acta paediatrica.

[7]  D. Paterson,et al.  Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials , 2017, The Journal of antimicrobial chemotherapy.

[8]  M. Sharland,et al.  High Reported Rates of Antimicrobial Resistance in Indian Neonatal and Pediatric Blood Stream Infections , 2017, Journal of the Pediatric Infectious Diseases Society.

[9]  Ramanan Laxminarayan,et al.  Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016 , 2017, Antibiotics.

[10]  S. Gandra,et al.  Impact of antibiotic policy on antibiotic consumption in a neonatal intensive care unit in India , 2017, Indian Pediatrics.

[11]  Paul Newell,et al.  Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Charu,et al.  Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. , 2016, The Lancet. Global health.

[13]  Z. Bhutta,et al.  Antimicrobial resistance-a threat to neonate survival. , 2016, The Lancet. Global health.

[14]  S. Cosgrove,et al.  Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.